Oakworth Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-19
| Closed | -$15.6K | – | 714 |
|
|
2023
Q3 | $15.6K | Hold |
19
| – | – | ﹤0.01% | 398 |
|
|
2023
Q2 | $13.7K | Buy |
+19
| New | +$13.7K | ﹤0.01% | 422 |
|
|
2022
Q4 | – | Sell |
-707
| Closed | -$487K | – | 596 |
|
|
2022
Q3 | $487K | Hold |
707
| – | – | 0.05% | 97 |
|
|
2022
Q2 | $418K | Hold |
707
| – | – | 0.04% | 109 |
|
|
2022
Q1 | $494K | Sell |
707
-75
| -10% | -$52.4K | 0.04% | 110 |
|
|
2021
Q4 | $494K | Buy |
782
+331
| +73% | +$209K | 0.04% | 109 |
|
|
2021
Q3 | $273K | Buy |
451
+366
| +431% | +$222K | 0.03% | 148 |
|
|
2021
Q2 | $47K | Hold |
85
| – | – | ﹤0.01% | 321 |
|
|
2021
Q1 | $40K | Buy |
+85
| New | +$40K | ﹤0.01% | 334 |
|
|
2019
Q2 | – | Sell |
-42
| Closed | -$17K | – | 646 |
|
|
2019
Q1 | $17K | Hold |
42
| – | – | ﹤0.01% | 404 |
|
|
2018
Q4 | $16K | Hold |
42
| – | – | ﹤0.01% | 399 |
|
|
2018
Q3 | $17K | Hold |
42
| – | – | ﹤0.01% | 413 |
|
|
2018
Q2 | $14K | Hold |
42
| – | – | ﹤0.01% | 438 |
|
|
2018
Q1 | $13K | Hold |
42
| – | – | ﹤0.01% | 425 |
|
|
2017
Q4 | $15K | Hold |
42
| – | – | ﹤0.01% | 413 |
|
|
2017
Q3 | $21K | Buy |
42
+40
| +2,000% | +$20K | 0.01% | 406 |
|
|
2017
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 611 |
|
|
2017
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 615 |
|
|
2016
Q4 | $1K | Hold |
2
| – | – | ﹤0.01% | 620 |
|
|
2016
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 595 |
|
|
2016
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 576 |
|
|
2016
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 531 |
|
|
2015
Q4 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 514 |
|